Iker Huerga
Data AnalystAI is analyzing your overall score…
Identifying your key strengths…
Evaluating your skill match against the job requirements…
Assessing your cultural and operational fit
AI is analyzing your overall score…
Identifying your key strengths…
Evaluating your skill match against the job requirements…
Assessing your cultural and operational fit
CEO at Pathos AI
Three-time founder. Two decades building AI systems for oncology, from Memorial Sloan Kettering to AstraZeneca to Tempus AI. Cancer survivor. I've sat in the waiting room as a patient. I've also sat in the boardroom deciding which drugs get developed. I know the gap between the two is unconscionable, and I know exactly where the system breaks. 90% of oncology drugs fail in clinical trials. Not because the biology is wrong, but because we lack the precision to match the right drug to the right patient at the right time. Pathos AI exists to close that gap. We are an AI and technology company that develops drugs, redesigning the entire business of drug development from first principles. Our Foundry platform combines the largest multimodal oncology dataset, thousands of AI agents, and AI-native teams of ~50 people doing the work of 500. We are not automating the old model. We are replacing it. If you are a builder, a scientist, an investor, or a partner who believes "standard of care" is not good enough, let's talk. Patients are waiting.
Mondragon Unibertsitatea
Master of Science (M.Sc.), Electrical Engineering and Computer Science
N/A – Present
Pathos
Chief Executive Officer
May 1, 2025 – Present
New York, United States
AstraZeneca
Chief AI & Data Scientist, Oncology R&D
July 1, 2024 – May 1, 2025
New York, United States
AstraZeneca
Chief AI & Data Scientist, Oncology R&D
July 1, 2020 – November 1, 2022
Tempus Labs, Inc.
Executive Vice President, Life Science Strategy & Real World Data
November 1, 2019 – July 1, 2024
Greater New York City Area
Da'at Technologies
Co-Founder, Chief Technology Officer - CTO
July 1, 2019 – January 1, 2020
Greater New York City Area
Several Companies
Investor & Scientific Advisory Board (SAB) member
November 1, 2018 – Present
Signifikance
Founder & CEO
September 1, 2014 – February 1, 2016
Greater New York City Area
Memorial Sloan Kettering Cancer Center
Director, Engineering and Applied Machine Learning
May 1, 2014 – July 1, 2019
Greater New York City Area
Memorial Sloan Kettering Cancer Center
Lead Data Scientist, Big Data Architect
May 1, 2014 – November 1, 2014
Greater New York City Area
Elsevier
Principal Software Engineer
January 1, 2013 – May 1, 2014
Greater Philadelphia Area
Elsevier
Sr. Semantic Software Engineer
September 1, 2011 – January 1, 2013
Greater Philadelphia Area
W3C
Advisory Committee Member
March 1, 2011 – November 1, 2011
LINKatu
Founder and CTO
November 1, 2009 – October 1, 2011
CICtourGUNE
Associated Researcher
December 1, 2008 – November 1, 2009
Mondragon University
Associated Researcher
February 1, 2007 – December 1, 2008
IKERLAN
Research Assistant
February 1, 2005 – February 1, 2007
Cultural Fit Analysis
The candidate's extensive experience in leadership, entrepreneurship, and scientific advisory roles, particularly in health-tech and biotech, indicates a strong drive for innovation and impact. Their background in building teams and fostering agile processes suggests adaptability and a collaborative mindset. However, the target role of 'Data Analyst' appears to be a significant mismatch with their senior executive and strategic leadership profile, which could lead to cultural misalignment regarding scope of responsibility and strategic influence.
Soft Skills & Operational Fit
The candidate demonstrates strong leadership, strategic vision, and team-building capabilities, evidenced by their roles as CEO, Chief AI & Data Scientist, and CTO. Their experience in scaling organizations and driving innovation suggests a proactive and results-oriented operational fit. The descriptions highlight a focus on maximizing ROI and transforming decision-making through data, indicating a strong business acumen.